BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20823141)

  • 1. Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.
    Uemura M; Yamamoto H; Takemasa I; Mimori K; Hemmi H; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
    Clin Cancer Res; 2010 Sep; 16(18):4636-46. PubMed ID: 20823141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection.
    Yamada D; Kobayashi S; Yamamoto H; Tomimaru Y; Noda T; Uemura M; Wada H; Marubashi S; Eguchi H; Tanemura M; Doki Y; Mori M; Nagano H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S355-64. PubMed ID: 21607773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
    Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
    World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cten signals through integrin-linked kinase (ILK) and may promote metastasis in colorectal cancer.
    Albasri A; Al-Ghamdi S; Fadhil W; Aleskandarany M; Liao YC; Jackson D; Lobo DN; Lo SH; Kumari R; Durrant L; Watson S; Kindle KB; Ilyas M
    Oncogene; 2011 Jun; 30(26):2997-3002. PubMed ID: 21339732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.
    Yang P; Chen T; Xu Z; Zhu H; Wang J; He Z
    Oncotarget; 2016 Jul; 7(27):42183-42194. PubMed ID: 27259250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer.
    Yamamoto H; Tei M; Uemura M; Takemasa I; Uemura Y; Murata K; Fukunaga M; Ohue M; Ohnishi T; Ikeda K; Kato T; Okamura S; Ikenaga M; Haraguchi N; Nishimura J; Mizushima T; Mimori K; Doki Y; Mori M
    Int J Oncol; 2013 Feb; 42(2):549-55. PubMed ID: 23258614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
    J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructose-bisphosphate aldolase A is a key regulator of hypoxic adaptation in colorectal cancer cells and involved in treatment resistance and poor prognosis.
    Kawai K; Uemura M; Munakata K; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2017 Feb; 50(2):525-534. PubMed ID: 28000858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloproteases meprin-ɑ (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.
    Wang X; Chen J; Wang J; Yu F; Zhao S; Zhang Y; Tang H; Peng Z
    BMC Cancer; 2016 Jul; 16():383. PubMed ID: 27378469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of TMEM176A is an independent prognostic marker and is involved in human colorectal cancer development.
    Gao D; Han Y; Yang Y; Herman JG; Linghu E; Zhan Q; Fuks F; Lu ZJ; Guo M
    Epigenetics; 2017 Jul; 12(7):575-583. PubMed ID: 28678648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of CDCP1 Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion and Migration.
    Chou CT; Li YJ; Chang CC; Yang CN; Li PS; Jeng YM; Chen ST; Kuo ML; Lin IC; Lin BR
    Ann Surg Oncol; 2015 Dec; 22(13):4335-43. PubMed ID: 25820997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.
    Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D
    Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Significance of Histone Lysine Demethylase JMJD3/KDM6B in Colorectal Cancer.
    Tokunaga R; Sakamoto Y; Nakagawa S; Miyake K; Izumi D; Kosumi K; Taki K; Higashi T; Imamura Y; Ishimoto T; Iwatsuki M; Baba Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Ann Surg Oncol; 2016 Feb; 23(2):678-85. PubMed ID: 26416711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
    Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR
    PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
    Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
    Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.